Phenotypes associated with this allele

• Allele Symbol: Mirc13⁺
• Allele Name: wild type
• Allele ID: MGI:6829616
• Summary: 1 genotype

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Mirc13^tm1Biat/Mirc13^+ Mirc4^tm1.1Biat/Mirc4^tm1.1Biat Tg(Ins2-cre)23Herr/0	involves: C57BL/6J * C57BL/6N * CBA/J	MGI:6829617

Genotype
MGI:6829617

cn1

• Allelic Composition: Mirc13^tm1Biat/Mirc13⁺; Mirc4^tm1.1Biat/Mirc4^tm1.1Biat; Tg(Ins2-cre)23Herr/0
• Genetic Background: involves: C57BL/6J * C57BL/6N * CBA/J

• ♀: phenotype observed in females
• ♂: phenotype observed in males
• N: normal phenotype

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:314874 )

N • streptozotocin-treated mice develop hyperglycemia as in wild-type mice

abnormal circulating glucose level ( J:314874 )

• streptozotocin-treated mice exhibit increased glucose serum levels that is not as severe as in wild-type mice

decreased physiological sensitivity to xenobiotic ( J:314874 )

• streptozotocin-treated mice exhibit reduced apoptosis and elevation of glucose serum levels compared with controls but not as much as in double null mice

endocrine/exocrine glands

abnormal pancreatic beta cell apoptosis ( J:314874 )

• streptozotocin-treated mice exhibit reduced apoptosis compared with controls but not as much as in double null mice

cellular

abnormal pancreatic beta cell apoptosis ( J:314874 )

• streptozotocin-treated mice exhibit reduced apoptosis compared with controls but not as much as in double null mice